Premium
Minimal residual disease analysis in childhood mature B‐cell leukaemia/lymphoma treated with AIEOP LNH‐97 protocol with/without anti‐CD20 administration
Author(s) -
Mussolin Lara,
Lovisa Federica,
Gallingani Ilaria,
Cavallaro Elena,
Carraro Elisa,
Damanti Carlotta C.,
Vinti Luciana,
Sala Alessandra,
Micalizzi Concetta,
Santoro Nicola,
Piglione Matilde,
Cellini Monica,
Buffardi Salvatore,
Buldini Barbara,
D’Amore Emanuele S. G.,
Biffi Alessandra,
Pillon Marta
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16531
Subject(s) - medicine , minimal residual disease , cd20 , rituximab , chemotherapy , pediatrics , lymphoma , immunophenotyping , b cell , acute lymphocytic leukemia , oncology , leukemia , immunology , antibody , lymphoblastic leukemia , antigen
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom